Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shixia Huang

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Cancer Research|February 5, 2008
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic functionSuleiman Massarweh, C Kent Osborne, Chad J Creighton, et al.
Oncogene|April 13, 2005
Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutationsXiaomei Zhang, Katrina Podsypanina, Shixia Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosisChad J Creighton, Angelo Casa, ZaWaunyka Lazard, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2021
Constitutive activation of mitogen-activated protein kinase kinase (MEK1) in ileal enterocytes leads to dysplasia and a predisposition to cancerBenjamin L Shneider, Nahir Cortes-Santiago, Deborah A Schady, et al.
Neoplasia (New York, N.Y.)|September 9, 2010
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesisMichael J Toneff, Zhijun Du, Jie Dong, et al.
Cancer Research|September 17, 2008
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenograftsChad J Creighton, Suleiman Massarweh, Shixia Huang, et al.
Breast Cancer Research and Treatment|September 17, 2020
Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancerLei Xue, Fengju Chen, Fei Yue, et al.
Plos One|May 9, 2015
Regulation of OsmiR156h through Alternative Polyadenylation Improves Grain Yield in RiceMeng Zhao, Binmei Liu, Kun Wu, et al.
British Journal of Cancer|May 28, 2020
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathwaysDivya Subramonian, Nikki Phanhthilath, Hannah Rinehardt, et al.
International Journal of Cancer|July 28, 2017
miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcomaLaura Satterfield, Ryan Shuck, Lyazat Kurenbekova, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|February 5, 2008
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic functionSuleiman Massarweh, C Kent Osborne, Chad J Creighton, et al.
Oncogene|April 13, 2005
Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutationsXiaomei Zhang, Katrina Podsypanina, Shixia Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosisChad J Creighton, Angelo Casa, ZaWaunyka Lazard, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2021
Constitutive activation of mitogen-activated protein kinase kinase (MEK1) in ileal enterocytes leads to dysplasia and a predisposition to cancerBenjamin L Shneider, Nahir Cortes-Santiago, Deborah A Schady, et al.
Neoplasia (New York, N.Y.)|September 9, 2010
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesisMichael J Toneff, Zhijun Du, Jie Dong, et al.
Cancer Research|September 17, 2008
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenograftsChad J Creighton, Suleiman Massarweh, Shixia Huang, et al.
Breast Cancer Research and Treatment|September 17, 2020
Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancerLei Xue, Fengju Chen, Fei Yue, et al.
Plos One|May 9, 2015
Regulation of OsmiR156h through Alternative Polyadenylation Improves Grain Yield in RiceMeng Zhao, Binmei Liu, Kun Wu, et al.
British Journal of Cancer|May 28, 2020
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathwaysDivya Subramonian, Nikki Phanhthilath, Hannah Rinehardt, et al.
International Journal of Cancer|July 28, 2017
miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcomaLaura Satterfield, Ryan Shuck, Lyazat Kurenbekova, et al.
Pageof 10